BACKGROUND AND AIM: The objective of this study was to determine outcome after living-donor kidney transplantation in a single-center institution in Germany. MATERIALS AND METHODS: From 1976 to May 2005, a total of 298 living-donor kidney transplants were performed at the University of Freiburg. Most recipients (78.8%) were placed on cyclosporine, mycophenolate mofetil, and corticosteroids maintenance immunosuppression. Cox proportional hazard model was applied to analyze predictors for patient and graft survival. Mean follow-up was 5.3 years. RESULTS: According to Kaplan-Meier calculation, 1-, 5-, and 10-year patient survival was 98.6, 92.7, and 86.8%, respectively. Kidney function rate was 95.5, 82.8, and 67.9%, respectively. A 5-year graft function rate continued to increase from 79.5% in patients transplanted before 1996 to 83.6% in patients transplanted thereafter. In a Cox regression model recipient age above 50 years, duration of dialysis above 2 years and preexisting type 1 diabetes mellitus were associated with a decreased patient survival. Graft survival was mostly influenced by the type of immunosuppression and preexisting hypertension of the recipient. CONCLUSIONS: Our results demonstrate that living-donor kidney transplantation is a highly effective therapy for patients with end stage renal failure. Updates in immunosuppression, recipient selection, and operative technique may have contributed to the improved graft survival over the past three decades.
BACKGROUND AND AIM: The objective of this study was to determine outcome after living-donor kidney transplantation in a single-center institution in Germany. MATERIALS AND METHODS: From 1976 to May 2005, a total of 298 living-donor kidney transplants were performed at the University of Freiburg. Most recipients (78.8%) were placed on cyclosporine, mycophenolate mofetil, and corticosteroids maintenance immunosuppression. Cox proportional hazard model was applied to analyze predictors for patient and graft survival. Mean follow-up was 5.3 years. RESULTS: According to Kaplan-Meier calculation, 1-, 5-, and 10-year patient survival was 98.6, 92.7, and 86.8%, respectively. Kidney function rate was 95.5, 82.8, and 67.9%, respectively. A 5-year graft function rate continued to increase from 79.5% in patients transplanted before 1996 to 83.6% in patients transplanted thereafter. In a Cox regression model recipient age above 50 years, duration of dialysis above 2 years and preexisting type 1 diabetes mellitus were associated with a decreased patient survival. Graft survival was mostly influenced by the type of immunosuppression and preexisting hypertension of the recipient. CONCLUSIONS: Our results demonstrate that living-donor kidney transplantation is a highly effective therapy for patients with end stage renal failure. Updates in immunosuppression, recipient selection, and operative technique may have contributed to the improved graft survival over the past three decades.
Authors: M J Bia; E L Ramos; G M Danovitch; R S Gaston; W E Harmon; A B Leichtman; P A Lundin; J Neylan; B L Kasiske Journal: Transplantation Date: 1995-08-27 Impact factor: 4.939
Authors: Rebecca L Tooher; M Mohan Rao; David F Scott; Daryl R Wall; David M A Francis; Franklin H G Bridgewater; Guy J Maddern Journal: Transplantation Date: 2004-08-15 Impact factor: 4.939
Authors: Bedeir Ali-El-Dein; Yasser Osman; Ahmed A Shokeir; Ahmed B Shehab El-Dein; Hussein Sheashaa; Mohamed A Ghoneim Journal: J Urol Date: 2003-06 Impact factor: 7.450
Authors: A Mehrabi; H Fonouni; M Golriz; B Schmied; M Tahmasbirad; J Weitz; M W Büchler; M Zeier; J Schmidt Journal: Chirurg Date: 2010-09 Impact factor: 0.955
Authors: Hyoung Won Koh; Kyunglim Koo; Chang Sik Shin; Hyung Sub Park; Jong Cheol Jeong; Sejoong Kim; Dong Wan Chae; Jong Jin Oh; Seok-Soo Byun; Taeseung Lee Journal: Korean J Transplant Date: 2020-09-30